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Abstract Intake of marine n-3 fatty acids has been shown to
have beneficial effects on cardiovascular disease. Gene ex-
pression analyses in peripheral blood mononuclear cells
(PBMCs) are used to understand the underlying mechanisms
of action of marine n-3 fatty acids. The aim of this review was
to summarize the effects mediated bymarine n-3 fatty acids on
gene expression in PBMCs. A systematic literature search was
conducted in PubMed in May 2014 and 14 papers were
included. Targeted gene expression studies were reported in
9 papers and focused on genes involved in lipid metabolism
and inflammation. Whole genome transcriptome analyses
were conducted in 5 papers, and processes and pathways related
to atherosclerotic plaque formation such as inflammation, oxi-
dative stress response, cell cycle, cell adhesion, and apopto-
sis were modulated after fish oil supplementation. PBMC
gene expression profiling has a potential to clarify further
the molecular effects of fish oil consumption on human
health.
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Introduction
Fish consumption reduces the risk of developing cardiovascular
disease (CVD) andCVDmortality [1, 2]. Intervention trials with
fish and fish oil containing the marine n-3 fatty acids
eicosapentaenoic acid (EPA, 20:5 n-3) and docosahexaenoic
(DHA, 22:6 n-3) have shown reduced total mortality and major
coronary event including fatal and nonfatal MI [3–6]. However,
recent meta-analyses and systematic reviews have shown that
contradictory results exist regarding the beneficial effects of
marine n-3 fatty acids on secondary prevention of coronary
heart disease [7, 8]. The health beneficial effects of marine n-3
fatty acids are suggested to be mediated by reducing plasma
triglycerides, reduced resting heart rate and blood pressure, and
n-3 fatty acids may improve vascular function and immune
response [9, 10]. Most organizations and national health coun-
cils recommend regular intake of fatty fish (1-2 servings per
week of fatty fish) in order to prevent CVD. Specific dietary
recommendations for the marine n-3 fatty acids are not widely
established and what those levels ought to be for particular
populations are unclear.
Marine n-3 fatty acids regulate expression of genes involved
in lipid metabolism and inflammation by acting as ligands for
the peroxisomal proliferator-activated receptors (PPARs) [11].
In addition, fatty acids have the ability to reduce the activation of
the transcription factor nuclear factor kappaB (NF-κB) probably
by interference with the PPARs [12, 13] or the Toll-like recep-
tors [14, 15]. Recently, the G protein-coupled receptor 120
(GPR120) has been characterized as n-3 fatty acid receptor/
sensor involved in mediating the anti-inflammatory effects of
n-3 fatty acids [16]. The ability of marine n-3 fatty acids to alter
gene expressionmay account for their potential health beneficial
effects. To further understand the underlying molecular mecha-
nisms of inclusion of fish oil and themarine n-3 fatty acids in the
human diet, the peripheral blood mononuclear cells (PBMCs)
may, therefore, provide a model system for studying gene
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expression of mediators involved in the early development of
atherosclerosis [17, 18]. The PBMCs, which include monocytes
and lymphocytes, are exposed to many of the same environ-
mental factors as metabolic tissues and the arterial wall. PBMCs
are also readily available, whichmake them suitable for studying
gene expression in dietary intervention studies.
The aim of this review is to summarize the effects of marine
n-3 fatty acids on gene expression in PBMCs and discuss the
findings in relation to human health.
Literature Search
A systematic literature search was conducted in Pubmed in
May 2014 using the following terms: “(fish oil and gene
expression and peripheral blood mononuclear cells), (fish oil
and transcriptome and peripheral blood mononuclear cells),
(fish oil and mRNA expression and peripheral blood mononu-
clear cells), (n-3 fatty acids and gene expression and peripheral
blood mononuclear cells), (n-3 fatty acids and transcriptome
and peripheral blood mononuclear cells), (n-3 fatty acids and
mRNA expression and peripheral blood mononuclear cells),
(fish oil and gene expression and mononuclear cells), (fish oil
and transcriptome andmononuclear cells), (fish oil and mRNA
expression and mononuclear cells), (n-3 fatty acids and gene
expression and mononuclear cells), (n-3 fatty acids and tran-
scriptome and mononuclear cells), (n-3 fatty acids and mRNA
expression and mononuclear cells)”. In total 157 instances of
articles were identified, but after removing duplicates, 32
papers were screened by reading abstracts (Fig. 1). In total 16
papers were excluded based on the following criteria of not be
a human study, not using fish oil or marine n-3 fatty acids, no
gene expression data, not an original paper (Fig. 1). After
reading 16 full-text papers, 2 more papers were excluded
because there was no effect of fish oil or n-3 fatty acids on
PBMC gene expression was shown in these papers (Fig. 1). In
total, 14 original papers were included in the review.
Fish Oil Intervention Studies and Targeted Gene
Expression Studies in PBMCs
Table 1 summarizes the effect of marine n-3 fatty acids from 9
targeted gene expression studies in PBMCs. In total, 7 fish oil
intervention studies have used PBMC gene expression data of
which onewas a postprandial study (Table 1). The duration of the
studies ranged from 4–12 weeks. Kaminski et al studied for the
first time in 1993 the effect of marine n-3 fatty acids on platelet-
derived growth factor (PDGF) gene expression in human mono-
nuclear cells (MNC) [19]. In a controlled randomized, observer-
blinded study with 14 healthy males, intake of 7 g/d of fish oil
concentrate (54 % EPA and 28.7 % DHA) reduced the mRNA
level of PDGF-A and B after both 1 and 6 weeks of intervention
(6 out of 7 subjects) [19]. In the control, group, receiving no
supplement, the expression level of PDGF-A remained unaltered
in 6 out of 7 subjects. To further examine other growth factors,
known to be involved in proliferation of endothelial cells,
Jendraschak et al analyzed the mRNA expression level of
platelet-derived endothelial cell growth factor (PD-ECGF),
insulin-like growth factor (IGF-1A, 1B), and transforming
growth factor-β1 (TGF-β1) [20]. The expression level of PD-
ECGF was constant, whereas gene expression of TGF-β1, IGF-
1A, and IGF-1B were varying over time and among subjects,
independently of each other [20]. Baumann et al performed a 4-
week randomized, investigator-blinded intervention trial with
7 g/d of fish oil concentrate (41.4 % EPA and 23.6 % DHA)
(n=7), 7 g/d of corn oil concentrate (50.1 % linoleic acid) (n=7),
or 7 g/d of olive oil concentrate (60.5 % oleic acid) (n=7) vs no
dietary intervention (n=7) [21]. The MNC gene expression
levels of PDGF-A, PDGF-B, and monocyte chemoattractant
protein-1 (MCP-1), also called chemokine (C-C motif) ligand 2
(CCL2), were reduced in the fish oil group in accordance with
the data from Kaminski et al [19]. Interleukin-10 (IL-10) and
heparin-bound epidermal growth factor (HB-EGF)mRNA levels
were not changed by fish oil supplementation [21]. The MNC
mRNA levels of PDGF-A, PDGF-B, MCP-1, IL-10, and HB-
EGF were not altered in the n-6 and n-9 fatty acid groups [21].
PDGF is a chemoattractant for neutrophils, monocytes, fibro-
blasts, and smooth muscle cells. Proliferation of vascular endo-
thelial and intimal smooth muscle cells, characteristic for athero-
sclerotic lesions, may be initiated and maintained by PDGF-like
protein secreted by monocytes, and fish oil consumption seems
Fig. 1 A flow chart of the PubMed search and selection of papers
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to regulate the expression of this gene in PBMCs, which may
have a health beneficial effect on development of atherosclerosis.
Weaver et al performed a dietary “cross-over” study in
which 27 healthy adults were given a controlled background
diet together with fish oil (775 mg EPA/d) and borage oil
(831 mg γ-linolenic acid (GLA18:3, n-6)/d) for 4 weeks
followed by a 2- week wash-out period [22]. Supplementation
of fish oil and borage oil induced a decrease in the expression
of phosphatidylinositol 3-kinase (PI3K) α and PIK3Kγ [22].
The expression of PI3Kβ, PI3Kδ, protein kinase B, also known
as Akt and NF-kB was not significantly altered during supple-
mentation [22]. PI3Kα and PIK3Kγ play an important roles in
eicosanoid formation and in cell growth, survival, and inflam-
mation by modulating Akt and NF-κB signaling, which in turn
influence the production of a variety of signaling molecules
such as cytokines. Furthermore, 8 cytokines known to play an
important role in the inflammatory response were measured in
the same study. The mRNA expression level of interleukin-
(IL)-1β, IL-10, and IL-23 were significantly decreased after
supplementation with fish oil and borage oil [22]. In addition,
the expression of IL-5 and IL-17 showed trends toward de-
creased expression after supplementation, whereas the expres-
sion of TNF-α and IL-6 were not changed [22]. This study
shows that 4-week supplementation with fish oil and borage oil
reduces the expression of PI3Kα and PIK3Kγ, which are early
steps in cellular signal transduction, as well as reduce expres-
sion of several important downstream genes such as different
interleukins. If the effect is mediated via altered formation of
inflammatory eicosanoids or a direct effect on gene regulation
is not known. It cannot be ruled out, that the effects may also
have been caused by a change in n-6 and n-3 PUFA content and
not only mediated by the marine n-3 fatty acids.
In a placebo-controlled double blind study with 22 moder-
ately hyperlipidemic obese humans consuming low-fat yogurt
enriched with a combination of low-dose PUFAs from fish oil
(100 mg n-3 fatty acids), polyphenols and L-carnitine (PPC)
twice a day for 12 weeks, the expression of genes involved in
lipid metabolism were compared with 20 matching partici-
pants ingesting low-fat yogurt [23]. The level of plasma free
fatty acids and triglycerides were significantly reduced in the
PPC group. In addition, the PBMC gene expression of
PPARα, carnitine palmitoyltransferase-1, CPT1A, and
CPT1B, carnitine acetyl-transferase (CrAT) and organic cat-
ion transporter 2 (OCTN2) was significantly increased in the
PPC group [23]. No change was seen in the control group
[23]. This study showed that a reduction in plasma free fatty
acids and triglycerides coincided with increased PBMC
mRNA expression level of genes encoding proteins involved
in fatty acid oxidation among subjects consuming PCC. Be-
cause CPT1 is regulating the capacity for mitochondrial fatty
acid oxidation, the increase in mRNA expression of CPT1
may stimulate oxidation and result in the subsequent observed
decrease in free fatty acids. The observed increase in the
mRNA level of PPARα may also partly explain the increased
expression of CPT1, CPT2, and OCTN2 [24]. However, the
effects seen in this study may also be related to intake of
carnitine and not only mediated by the marine n-3 fatty acids.
Cruz-Teno et al performed a randomized dietary interven-
tion study with 75 subjects with metabolic syndrome allocated
to 1 of 4 diets; high saturated fatty acids (HSFA); high mono-
unsaturated fatty acids (HMUFA) and 2 low-fat, high complex
carbohydrate (LFHCC) diets, supplemented with n-3 fatty
acids (LFHCC n-3) or placebo (LFHCC), for 12 weeks,
followed by a postprandial challenge [25•]. In the HMUFA
diet group and 4 hours after the fat overload, a significant
postprandial increase in the mRNA expression level of nuclear
factor of kappa light polypeptide gene enhancer in B-cells
inhibitor, alpha (IkB)-α compared with HSFA and LFHCC n-
3 diets was observed [25•]. In contrast, at fasting levels, after
12 weeks consumption of LFHCC n-3 diet, the expression
level of IKB-α mRNAwas higher compared with HSFA and
HMUFA diets. Intake of the 4 different fat load breakfasts
induced an increase in the mRNA expression of TNFα, me-
talloproteinase 9 (MMP-9), and IL-6 independently of the diet
consumed, reflecting an acute inflammatory response during
the postprandial period. No changes in NF-κB p65 subunit
(p65), macrophage migration inhibitory factor (MIF) and
MCP-1 mRNA levels were observed after intake of any of
the 4 different diets [25•]. The postprandial plasma protein
concentration of MCP-1 was reduced after intake of HMUFA
and LFHCC n-3 diets compared with HSFA diet. After the fat
load, an increase in the postprandial plasma protein levels of
IL-6 independently of diet consumed was observed. No ef-
fects were found by diet on plasma protein level of TNFα
[25•].
We have also performed a postprandial study where 3
different test meals were consumed by 14 healthy women in
a fixed order with 14 days wash-out between each test meal
[26•]. The test meals consisted of 3 different 150 g chocolate
cakes enriched with coconut fat [43 % energy as saturated fat
and 1 % energy as alpha-linolenic acid (ALA)], linseed oil
(14 % energy as ALA and 30 % energy as saturated fat), and
cod liver oil (5 % energy as EPA and DHA and 5 % energy as
ALA in addition to 31 % energy as saturated fat). At 3 hours
after intake of the test meal, the plasma triglycerides increased
in all groups, whereas no significant differences in triglycer-
ides were observed after 6 hours compared with baseline in
any of the groups. The mRNA expression level of IL-8 was
significantly upregulated after intake of the cod liver oil cake
at 6 hours compared with fasting level. This increase was
significantly different from the effect observed after intake
of linseed oil cake. No increase in plasma protein level of
IL-8 was observed for any of the test meals. The mRNA level
of CPT1Awas also significantly increased 6 hours after intake
of cod liver oil cake compared with 3 hours. In addition,
ex vivo cultured PBMCs were incubated for 24 hours with
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60 μM of EPA. Incubation with EPA significantly increased
the mRNA expression level of IL-8 and CPT1A compared
with unstimulated cells [26•].
Fish Intervention Studies and Targeted Gene Expression
Studies in PBMCs
Of the total 9 papers on targeted gene expression analysis, 2
dietary intervention studies with fatty or lean fish have been
reported. De Mello et al showed in a 8-week randomized
study with 3 groups, fatty fish diet (n=11, 0.89 g EPA+
DHA/d), lean fish diet (n=11, 0.43 g EPA+DHA/d) and
control diet (n=6, 0.18 g EPA+DHA/d) among patients with
coronary heart disease, that 4 portions of fish per week for
8 weeks did not differently change the gene expression of
TNF, IL-1β, IL-6, chemokine (C-C motif) ligand 2 (CCL-2),
CCL-5, intercellular cell adhesion molecule-1 (ICAM1), vas-
cular cell adhesion molecule -1 (VCAM1), and E- and P-
selectin during the intervention in neither the fatty fish or the
lean fish group [27]. We have also shown in a 15-day ran-
domized study with 3 groups, fatty fish diet (n=11, 3.1 g
EPA+DHA/d), lean fish diet (n=9, 0.13 g EPA+DHA/d),
and control diet (n=10, 0 g EPA+DHA/d) among healthy
adults, that 150 g of fish per day did not change the gene
expression of stearoyl-CoA desaturase-1 (SCD-1) and fatty
acid synthase (FAS) in PBMCs compared with the control
group [28]. We did, however, observe an increase in FAS
mRNA level within the salmon group. The plasma triglycer-
ide levels were significantly decreased in both fish groups
compared with the control group, and HDL-cholesterol was
significantly increased after intake of salmon compared with
the control group. Total-cholesterol and LDL-cholesterol were
not changed between or within any of the groups during the
intervention [28].
Overall, few targeted gene expression studies have been
performed and a limited number of genes related to lipid
metabolism (such as PPARα, CPT1, FAS, and SCD-1) have
been examined. Most of the effects seen are related to genes
involved in immune function. In many of these studies the
effect has been studied within the group receiving fish oil and
not in comparison with the control group.
Fish Oil Interventions and Whole Genome Transcriptomics
in PBMCs
PBMC transcriptome analyses in human intervention studies
with fish oil were reported in 5 papers and are summarized in
Table 2. Three of the studies were double-blinded randomized
placebo-controlled studies and all used fish oil (1.6 g/d EPA+
DHA/d-3 g/d EPA+DHA) and included healthy adults or
elderly subjects, subjects with Alzheimer disease and obese
insulin resistant subjects. The duration of the studies ranged
from 6–26 weeks (Table 2).
Bouwens et al [29] first reported the effect of fish oil sup-
plementation on whole genome gene expression profiles in
human PBMCs in 2009. A double-blinded randomized inter-
vention trial in an elderly population was performed. The
triglyceride levels were significantly reduced in the fish oil
group compared to the high oleic sunflower oil (HOSO, con-
trol) group, but no change in CRP level was observed in any of
the groups. Within the fish oil group consuming 1.8 g/d EPA+
DHA (n=23), 1040 gene transcripts were regulated after
26 weeks of intervention. Within the high oleic sunflower oil
(HOSO, control) group (n=25), 298 genes were regulated after
26 weeks of intervention. In total 140 genes were overlapping
between the groups, and the direction of change was the same
in both groups. Pathways analysis (using GenMAPP) showed
that fish oil supplementation for 26 weeks significantly de-
creased the expression of genes involved in inflammatory
pathways, such as eicosanoid synthesis, interleukin signaling,
and MAP kinase signaling. Fish oil supplementation also sig-
nificantly decreased expression of genes related to atheroscle-
rotic processes, such as cell adhesion, scavenger receptor activ-
ity, and adipogenesis. Other pathway analysis and gene set
enrichment analyses (GSEA analysis) showed a decrease in
similar inflammatory signaling pathways as described above
in the fish oil group. In addition, these analyses also showed
that genes involved in nuclear transcription factor kB (NF-kB)
and Toll-like receptor signaling were decreased in the fish oil
group. A decrease in oxidative stress, cell adhesion, cell cycle,
PPAR and LXR/RXR activation, and hypoxia signaling was
also observed in the fish oil group. In the HOSO group,
pathways analysis showed a decreased expression of genes
involved in inflammation and cell adhesion [29].
Vedin et al showed in a 24-week double-blinded random-
ized, placebo-controlled fish oil study (2.3 g/d EPA+DHA)
among 16 subjects with Alzheimer disease that 19 genes (with
a false discovery rate of 10 %) were changed in the fish oil
group [30•]. In total, 9 genes were upregulated by the fish oil
supplementation, and of these, 1 gene was also upregulated in
the control group (corn oil), and 1 gene was significantly
different in fold change between the 2 groups (CD63 mole-
cule). In total, 10 genes were downregulated by the fish oil
supplementation, and of these, 4 genes were significantly
different in fold change between the groups [Ras homolog
gene family, member B (RHOB), LOC 3999491 protein
(LOC399491), zinc finger protein 24 (ZNF24), and Anaphase
promoting complex subunit 5 (ANAPC5)]. Many of the mod-
ulated genes are involved in inflammation regulation, and
neurodegeneration and in ubiquitination processes [30•].
Rudkowska et al showed in a 8 weeks randomized con-
trolled crossover study with fish oil (1.8 g/d EPA+DHA) and
fish oil plus fish gelatin (+FG) with 16 obese insulin-resistant
subjects that 805 genes were regulated in the fish oil group
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[31]. A decrease in fasting triglyceridesin both groups, but no
changes in total cholesterol, LDL-cholesterol, HDL-cholester-
ol, and circulating inflammatory markers such as CRP, IL-6,
and TNFα were observed. Among the 805 genes, 65 % (524)
were downregulated and 35 % (281) were upregulated. In the
fish oil plus fish gelatin group, 184 genes were regulated after
an 8-week intervention (59 % (109) downregulated and 41 %
(75) were upregulated). Of these genes, only 3 genes were
overlapping in both supplementation periods [fatty acid
desaturase 1 (FADS1), free fatty acid receptor 3 (EFAR3),
and ectodysplasin (EDA)]. Pathways analysis (Ingenuity)
showed that oxidative stress response mediated by nuclear
factor (erythroid-derived 2) like 2 (NrF2), PPARα, hypoxia-
inducible factor (HIF) and NF-κB signaling pathways were
changed in both groups during the intervention but to different
extents [31]. Rudkowska et al have also investigated the
PBMC gene expression changes following fish oil supple-
mentation (3 g/d EPA+DHA) for 6 weeks among 29 healthy
adults (12 male and 17 females) [32]. The study was not a
randomized study and was without a control group. They
found that 170 genes were regulated after a 6-week interven-
tion (47 % (80) downregulated and 53% (90) upregulated). In
male subjects, 610 genes were differently expressed (46 %
(283) down-regulated and 54 % (327) upregulated) by fish oil
supplementation. In females, only 250 genes were differently
expressed (49 % (122) downregulated and 51 % (128) upreg-
ulated) by fish oil supplementation. Of these genes, only 9
genes were overlapping. Pathways analysis (Ingenuity)
showed that oxidative stress response genes mediated by
NrF2, PPARα, HIF and NF-κB signaling pathway were
changed among males and females but to different extend. A
decrease in fasting plasma triglycerides among males and
females was observed, however, no other changes in total
cholesterol, LDL-cholesterol, and circulating inflammatory
markers such as CRP, IL-6, TNFα was observed [32].
In a 7-week double-blinded randomized controlled fish oil
study (1.6 g/d EPA+DHA) with healthy adults, we have
recently observed that 470 genes (P<0.05) were differently
expressed between the fish oil group and the HOSO group
[33••]. Two hundred-and thirty-six genes were upregulated
and 234 were downregulated in the fish oil group compared
with the HOSO group. Among the upregulated genes, several
biological processes were enriched such as cell cycle and
DNA packing and chromosome organization. We found that
11 genes were significantly changed in the fish oil group
(FDR q-value <10 %), and none in the HOSO group. Gene
set enrichment analysis (GSEA) showed that in particular cell
cycle, apoptosis, immune response, protein folding and mat-
uration and DNA damage were significantly regulated in the
fish oil group compared with the HOSO group. Moreover,
Gene transcripts with common motifs for 35 known transcrip-
tion factors including E2F, TP53, HIF, and ATF4 were upreg-
ulated after intake of fish oil compared with HOSO [33••].
Overall, 5 papers have reported using whole genome tran-
scriptomics in fish oil intervention studies. Annotation and path-
ways analysis showed that fish oil supplementation modulated
the expression of genes involved in inflammatory pathways,
such as eicosanoid synthesis, interleukin signaling, and MAP
kinase signaling, oxidative stress response, cell cycle, cell adhe-
sion, apoptosis, scavenger receptor activity, adipogenesis, protein
folding, maturation, and DNA damage [29–32, 33••]. Many of
these are anti-atherogenic and anti-inflammatory genes, which
play a role in several processes involved in atherosclerotic plaque
formation. PBMCs, consisting of monocytes and lymphocytes
are cells central in these processes including adhesion, infiltra-
tion, and foam cell formation, and, therefore, it seems like whole
genome transcriptomics can be used to identify novel pathways
modulated by intake of fish oil. Data from fish oil supplementa-
tion studies further indicates that these effects may be mediated
via many transcription factors and signaling pathways, such as
NF-κB, Toll-like receptor signaling, PPAR and LXR/RXR acti-
vation and hypoxia signaling [29, 33••]. The studies summarized
in this paper have different duration, doses and study subjects,
but overall they show that fish oil supplementation may influ-
ence several biological pathways and processes via different
transcription factors. The discrepancy between the studies by
Bouwens et al [29] and Rudkowska et al [31, 32] on PPARα
activation, may be caused by differences in the duration of the
studies or the age and genotype of the study subjects. Because it
has been shown that the response of fish oil on triglycerides
depends on sex and genotype [34], genetic differences may
cause the variation in gene expression responses observed in
these intervention studies. Another explanation could be that
changes in gene expression are reflecting the response of
PBMCs to EPA-DHA-induced systemic adaptations in the body
and may, therefore, not be a direct effect of EPA+DHA on
mononuclear cells. The major limitation in these transcriptomic
studies is that most of the studies (4 out of 5) analyzed the within
group changes, rather than between group differences.
Conclusions
PBMC gene expression analysis in human dietary interven-
tion studies with fish oil or fatty fish can be a powerful tool to
understand the underlying molecular mechanisms explaining
the association between high intakes of marine n-3 fatty acids
and effects on morbidity and mortality from CVD. These
studies show the potential of PBMC gene expression profiling
to investigate the effects of nutrition on human health. Gene
expression profiling seems to be more sensitive to fish oil
interventions than the traditional biochemical parameters mea-
sured in circulation and enable us to study gene expression of
mediators involved in the early development of atherosclero-
sis. Future studies should integrate gene expression patterns
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with biochemical parameters to determine the precise mecha-
nisms of action of EPA and DHA in humans. More emphasis
should also be on examining the gene expression profiles in
PBMCs in responders versus non-responders in order to un-
derstand the influence of genetic factors on the effect of fish
oil on lipids and inflammatory markers.
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